Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction. He also discusses how the company is tackling the issue of counterfeit drugs, as well as the other projects they have on the pipeline. This interview was recorded on December 10 at the Economic Club of Washington DC. 

<p>Eli Lilly is the world's most valuable drug company, known for its blockbuster anti-obesity drugs that's transforming America. In an episode of "The David Rubenstein Show: Peer to Peer Conversations," CEO Dave Ricks talks about how the company will begin studies this year to see if its weight-loss medicines can also be used to treat addictive behaviors like alcohol abuse, smoking and drug addiction. He also discusses how the company is tackling the issue of counterfeit drugs, as well as the other projects they have on the pipeline. This interview was recorded on December 10 at the Economic Club of Washington DC.&nbsp;</p>

What makes a great leader? How can leadership be developed into a force for true achievement? The David Rubenstein Show: Peer-to-Peer Conversations explores successful leadership through the personal and professional choices of the most influential people in business. Renowned financier and philanthropist David Rubenstein travels the country talking to leaders to uncover their stories and their path to success. Each episode features an interview with one business leader.

Renowned financier and philanthropist David Rubenstein travels the country talking to leaders to uncover their stories and their path to success

The David Rubenstein Show

Dave Ricks

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/d8de9773-58b4-466e-8aa0-b26000e76903/transcript

Advertisement